These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 23049641)

  • 41. Effect of short-term losartan treatment in patients with primary aldosteronism and essential hypertension.
    Zacharieva S; Atanassova I; Natchev E; Orbetzova M; Tzingilev D
    Methods Find Exp Clin Pharmacol; 2001 Apr; 23(3):153-6. PubMed ID: 11523316
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Comparison of adrenal vein sampling and computed tomography in the differentiation of primary aldosteronism.
    Magill SB; Raff H; Shaker JL; Brickner RC; Knechtges TE; Kehoe ME; Findling JW
    J Clin Endocrinol Metab; 2001 Mar; 86(3):1066-71. PubMed ID: 11238487
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Clinical characteristics and surgery outcomes of unilateral nodular adrenal hyperplasia in primary aldosteronism: study of 145 cases].
    Wu JC; Tang ZY; Zhang W; Ling DY; Hou RF; Wang WQ; Li XY; Ning G
    Zhonghua Yi Xue Za Zhi; 2006 Dec; 86(46):3302-5. PubMed ID: 17313818
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Prevalence and clinical characteristics of primary aldosteronism in a tertiary-care center in Korea.
    Yoon M; Hong N; Ha J; Lee CJ; Ku CR; Rhee Y; Park S
    Hypertens Res; 2022 Sep; 45(9):1418-1429. PubMed ID: 35681044
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Evidence for an increased rate of cardiovascular events in patients with primary aldosteronism.
    Milliez P; Girerd X; Plouin PF; Blacher J; Safar ME; Mourad JJ
    J Am Coll Cardiol; 2005 Apr; 45(8):1243-8. PubMed ID: 15837256
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Primary Aldosteronism: Present and Future.
    Funder JW
    Vitam Horm; 2019; 109():285-302. PubMed ID: 30678860
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Clinical Outcomes After Unilateral Adrenalectomy for Primary Aldosteronism.
    Vorselaars WMCM; Nell S; Postma EL; Zarnegar R; Drake FT; Duh QY; Talutis SD; McAneny DB; McManus C; Lee JA; Grant SB; Grogan RH; Romero Arenas MA; Perrier ND; Peipert BJ; Mongelli MN; Castelino T; Mitmaker EJ; Parente DN; Pasternak JD; Engelsman AF; Sywak M; D'Amato G; Raffaelli M; Schuermans V; Bouvy ND; Eker HH; Bonjer HJ; Vaarzon Morel NM; Nieveen van Dijkum EJM; Vrielink OM; Kruijff S; Spiering W; Borel Rinkes IHM; Valk GD; Vriens MR;
    JAMA Surg; 2019 Apr; 154(4):e185842. PubMed ID: 30810749
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Outcomes analysis of surgical and medical treatments for patients with primary aldosteronism.
    Park KS; Kim JH; Yang YS; Hong AR; Lee DH; Moon MK; Choi SH; Shin CS; Kim SW; Kim SY
    Endocr J; 2017 Jun; 64(6):623-632. PubMed ID: 28458337
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Long-term follow-up after adrenalectomy for primary aldosteronism.
    Meyer A; Brabant G; Behrend M
    World J Surg; 2005 Feb; 29(2):155-9. PubMed ID: 15650803
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Cardiovascular events and target organ damage in primary aldosteronism compared with essential hypertension: a systematic review and meta-analysis.
    Monticone S; D'Ascenzo F; Moretti C; Williams TA; Veglio F; Gaita F; Mulatero P
    Lancet Diabetes Endocrinol; 2018 Jan; 6(1):41-50. PubMed ID: 29129575
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Clinical and pathological diversity of primary aldosteronism, including a new familial variety.
    Gordon RD; Stowasser M; Tunny TJ; Klemm SA; Finn WL; Krek AL
    Clin Exp Pharmacol Physiol; 1991 May; 18(5):283-6. PubMed ID: 2065471
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Hypertension Management in Stroke Prevention: Time to Consider Primary Aldosteronism.
    McCarthy J; Yang J; Clissold B; Young MJ; Fuller PJ; Phan T
    Stroke; 2021 Oct; 52(10):e626-e634. PubMed ID: 34428932
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Primary aldosteronism - treatment options.
    Young WF
    Growth Horm IGF Res; 2003 Aug; 13 Suppl A():S102-8. PubMed ID: 12914736
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Primary aldosteronism: challenges in diagnosis and management.
    Galati SJ
    Endocrinol Metab Clin North Am; 2015 Jun; 44(2):355-69. PubMed ID: 26038205
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Is primary aldosteronism underdiagnosed in clinical practice?
    Fiquet-Kempf B; Launay-Mignot P; Bobrie G; Plouin PF
    Clin Exp Pharmacol Physiol; 2001 Dec; 28(12):1083-6. PubMed ID: 11903321
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Adrenalectomy reverses myocardial fibrosis in patients with primary aldosteronism.
    Lin YH; Wu XM; Lee HH; Lee JK; Liu YC; Chang HW; Lin CY; Wu VC; Chueh SC; Lin LC; Lo MT; Ho YL; Wu KD;
    J Hypertens; 2012 Aug; 30(8):1606-13. PubMed ID: 22688266
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [The aldosterone to Renin ratio in secondary hypertension].
    Seiler L; Reincke M
    Herz; 2003 Dec; 28(8):686-91. PubMed ID: 14689102
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Primary aldosteronism is comprised of primary adrenal hyperplasia and adenoma.
    Biglieri EG; Kater CE; Arteaga EE
    J Hypertens Suppl; 1984 Dec; 2(3):S259-61. PubMed ID: 6599673
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Renal cysts and hypokalemia in primary aldosteronism: results of long-term follow-up after treatment.
    Novello M; Catena C; Nadalini E; Colussi GL; Baroselli S; Chiuch A; Lapenna R; Bazzocchi M; Sechi LA
    J Hypertens; 2007 Jul; 25(7):1443-50. PubMed ID: 17563567
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The aldosterone/renin ratio as a screening test for primary aldosteronism.
    Rayner BL; Opie LH; Davidson JS
    S Afr Med J; 2000 Apr; 90(4):394-400. PubMed ID: 10957926
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.